Listen to the Interview MP3 audio file
Download the Interview MP3 audio file
Transcript:
Read the PDF of: Special Solari Report: What Is the Real Cost of Vaccines? Part I with Professor Dolores Cahill 
“Action is the real measure of intelligence.” ~ Napoleon Hill
By Catherine Austin Fitts
The marvelous Senta Depuydt who leads Children’s Health Defense-Europe suggested that Professor Dolores Cahill and I start to map out the real economic costs of vaccines, vaccine injury, and what I call “the injection fraud.” And so we began with this first discussion.
If you are not familiar with Professor Cahill, this is someone you want to know and follow. She is a world-renowned expert in high-throughput proteomics technology development and automation, high content protein arrays and their biomedical applications, including in biomarker discovery and diagnostics. Prof. Cahill pioneered this research area at the Max Planck Institute of Molecular Genetics in Berlin, Germany, and holds several international patents in this field with research, biomedicine, and diagnostic applications. Prof. Cahill has over 20 years of expertise in high-throughput protein & antibody array, automation, proteomics technology development & biomedical applications in biomarker discovery, and diagnostics & personalized medicine. Since 2005 to present, she has been full professor of translational science, School of Medicine, University College Dublin, and an academic, researcher, lecturer, and module coordinator in pathology teaching, School of Medicine & Conway Institute. She also spent 15 years as Irish, EU, & international expert & advisor including seconded national expert to the European Commission. She is company co-founder & shareholder (1997-2019) of Protagen AG in Germany (https://www.protagenproteinservices.com/). Protagen Protein Services (2012-2019) contract services to healthcare sector & pharmaceutical industry (https://protagenproteinservices.com/). Since 2016, she has been co-founding shareholder and advisory board member of Prof. Stephen Pennington’s UCD School of Medicine/Conway Institute spin-out company, Atturos Ltd. working to improve prostate cancer diagnosis (http://atturos.com/). Prof. Cahill has a total of over 5940 citations, H (Hirsh)-index of 35, i10-index of 48. She has successfully obtained and project managed as Principal Investigator eight EU Programme funding grants from FP4, FP5, FP6, FP7 and Horizon 2020, Science Foundation Ireland, Enterprise Ireland, Health Research Board funding in companies and universities.
Related Reading:
Dolores Cahill’s Official Website
